PRA says Clinstar Takeover Offers Quicker and Cheaper Patient Enrollment
US CRO PRA international has expanded its presence in Eastern Europe with the acquisition of privately-owned trial services firm ClinStar.
US CRO PRA international has expanded its presence in Eastern Europe with the acquisition of privately-owned trial services firm ClinStar.
Endo says it will expand capacity at its generic manufacturing subsidiary Qualitest in light of quality lapses and product recall.
AstraZeneca has renewed its European drug distribution contract with Yusen Logistics.
Inspections in countries not expected to confirm API quality or seek exemption from new EU import regs “cannot be seen as a solution” to shortage concerns says the MHRA.
Eisai says its US supply agreement with DSM offers an alternate manufacturing facility and ensures a strengthened supply line.
update
SAFC will expand manufacturing capacity at its facility in Irvine, Scotland, to include large-scale production of bulk dry powder media and reagents to save EU clients’ money in shipment costs.
Chinese regulators want to improve how drugs are developed, reviewed and distributed in the country.
Sanofi has entered into an agreement to produce an API for French company DBV Technologies.